Postprandial Insulin Resistance in Zucker Diabetic Fatty Rats is Associated with Parasympathetic-Nitric Oxide Axis Deficiencies

Journal of Neuroendocrinology

Volumn 24, Issue 10, 2012, Pages 1346-1355

  Afonso, R A ^a   Fernandes, A B ^a   Santos, C ^b   Ligeiro, D ^c   Ribeiro, R T ^a   Lima, I S ^a   Patarrao, R S ^a   Videira, P A ^a   Caldeira, J ^c   Macedo, M P ^a,d  

^a NOVA MEDICAL SCHOOL   (Portugal)

^b UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^c HOSPITAL PULIDO VALENTE   (Portugal)

^d Portuguese Diabetes Association   (Portugal)

Author keywords

Glutathione; Insulin action; Nitric oxide; Parasympathetic nerves; Postprandial state; Zucker diabetic fatty

Indexed keywords

ATROPINE; GLUCOSE; GLUTATHIONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SYNTHETASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPERGLYCEMIA; HYPOINSULINEMIA; HYPOTHESIS; INSULIN RESISTANCE; LIVER; MALE; MEAL; NONHUMAN; PARASYMPATHETIC FUNCTION; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ZUCKER DIABETIC FATTY RAT; ZUCKER RAT;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE; INSULIN; INSULIN RESISTANCE; LIVER; MALE; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PARASYMPATHETIC NERVOUS SYSTEM; POSTPRANDIAL PERIOD; RATS, ZUCKER;

EID: 84866314969     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02341.x     Document Type: Article

References (55)

1. Martyn JA, Kaneki M, Yasuhara S. Obesity-induced insulin resistance and hyperglycemia: etiologic factors and molecular mechanisms. Anesthesiology 2008; 109: 137-148.
2. Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ. Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol 2005; 42: 162-170.
3. Szocs Z, Brunmair B, Stadlbauer K, Nowotny P, Bauer L, Luger A, Furnsinn C. Age-dependent development of metabolic derangement and effects of intervention with pioglitazone in Zucker diabetic fatty rats. J Pharmacol Exp Ther 2008; 326: 323-329.
4. Topp BG, Atkinson LL, Finegood DT. Dynamics of insulin sensitivity, -cell function, and -cell mass during the development of diabetes in fa/fa rats. Am J Physiol Endocrinol Metab 2007; 293: E1730-E1735.
5. Jones HB, Nugent D, Jenkins R. Variation in characteristics of islets of Langerhans in insulin-resistant, diabetic and non-diabetic-rat strains. Int J Exp Pathol 2010; 91: 288-301.
6. Ceriello A, Colagiuri S, Gerich J, Tuomilehto J. Guideline for management of postmeal glucose. Nutr Metab Cardiovasc Dis 2008; 18: S17-S33.
7. Hanefeld M, Temelkova-Kurktschiev T. Control of post-prandial hyperglycemia - an essential part of good diabetes treatment and prevention of cardiovascular complications. Nutr Metab Cardiovasc Dis 2002; 12: 98-107.
8. Lautt WW, Macedo MP, Sadri P, Takayama S, Duarte Ramos F, Legare DJ. Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am J Physiol Gastrointest Liver Physiol 2001; 281: G29-G36.
9. Xie H, Lautt WW. Insulin resistance of skeletal muscle produced by hepatic parasympathetic interruption. Am J Physiol 1996; 270: E858-E863.
10. Guarino MP, Afonso RA, Raimundo N, Raposo JF, Macedo MP. Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitizing substance action. Am J Physiol Gastrointest Liver Physiol 2003; 284: G588-G594.
11. Guarino MP, Correia NC, Lautt WW, Macedo MP. Insulin sensitivity is mediated by the activation of the ACh/NO/cGMP pathway in rat liver. Am J Physiol Gastrointest Liver Physiol 2004; 287: G527-G532.
12. Moore MC, Satake S, Baranowski B, Hsieh PS, Neal DW, Cherrington AD. Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol Endocrinol Metab 2002; 282: E286-E296.
13. Fernandes AB, Patarrao RS, Videira PA, Macedo MP. Understanding postprandial glucose clearance by peripheral organs: the role of the hepatic parasympathetic system. J Neuroendocrinol 2011; 23: 1288-1295.
14. Sadri P, Lautt WW. Blockade of nitric oxide production in the liver causes insulin resistance. Proc West Pharmacol Soc 1998; 41: 37-38.
15. Sadri P, Lautt WW. Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol 1999; 277: G101-G108.
16. Guarino MP, Macedo MP. Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol 2006; 147: 959-965.
17. Sadri P, Reid MA, Afonso RA, Schafer J, Legare DJ, Paula Macedo M, Wayne Lautt W. Meal-induced insulin sensitization in conscious and anaesthetized rat models comparing liquid mixed meal with glucose and sucrose. Br J Nutr 2006; 95: 288-295.
18. Huang CS, Chang LS, Anderson ME, Meister A. Catalytic and regulatory properties of the heavy subunit of rat kidney gamma-glutamylcysteine synthetase. J Biol Chem 1993; 268: 19675-19680.
19. Afonso RA, Ribeiro RT, Fernandes AB, Patarrao RS, Macedo MP. Hepatic-dependent and -independent insulin actions are impaired in the obese Zucker rat model. Obes Res 2007; 15: 314-321.
20. Lautt WW, Wang X, Sadri P, Legare DJ, Macedo MP. Rapid insulin sensitivity test (RIST). Can J Physiol Pharmacol 1998; 76: 1080-1086.
21. Komjati M, Astner-Kremsamayr H, Waldhausl W, Reitgruber W, Breitenecker F, Troch I. Interaction of sympathomimetics and insulin with hepatic glucose production by isolated perfused rat livers: effects of continuous versus pulsatile infusion. Endocrinology 1988; 123: 1798-1807.
22. Patarrao RS, Lautt WW, Afonso RA, Ribeiro RT, Guarino MP, Fernandes AB, Boavida JM, Macedo MP. Meal-induced insulin sensitization and its parasympathetic regulation in humans. Can J Physiol Pharmacol 2008; 86: 880-888.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 2001; 25: 402-408.
24. White CC, Viernes H, Krejsa CM, Botta D, Kavanagh TJ. Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem 2003; 318: 175-180.
25. Asensi M, Sastre J, Pallardo FV, Garcia de la Asuncion J, Estrela JM, Vina J. A high-performance liquid chromatography method for measurement of oxidized glutathione in biological samples. Anal Biochem 1994; 217: 323-328.
26. Bredt DS, Snyder SH. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 1994; 63: 175-195.
27. Afonso RA, Patarrao RS, Macedo MP, Carmo MM. Carvedilol action is dependent on endogenous production of nitric oxide. Am J Hypertens 2006; 19: 419-425.
28. Lang CH, Bagby GJ, Hargrove DM, Hyde PM, Spitzer JJ. Alterations in glucose kinetics induced by pentobarbital anesthesia. Am J Physiol 1987; 1: E657-E663.
29. Afonso RA, Lautt WW, Schafer J, Legare DJ, Oliveira AG, Macedo MP. High-fat diet results in postprandial insulin resistance that involves parasympathetic dysfunction. Br J Nutr 2010; 104: 1450-1459.
30. Van De Borne P, Hausberg M, Hoffman RP, Mark AL, Anderson EA. Hyperinsulinemia produces cardiac vagal withdrawal and nonuniform sympathetic activation in normal subjects. Am J Physiol 1999; 276: R178-R183.
31. Ribeiro RT, Lautt WW, Legare DJ, Macedo MP. Insulin resistance induced by sucrose feeding in rats is due to an impairment of the hepatic parasympathetic nerves. Diabetologia 2005; 48: 976-983.
32. Ribeiro RT, Afonso RA, Macedo MP. Hepatic parasympathetic role in insulin resistance on an animal model of hypertension. Metabolism 2007; 56: 227-233.
33. Patarrao RS, Lautt WW, Guarino MP, Afonso RA, Ribeiro RT, Fernandes AB, Boavida JM, Macedo MP. A new technique to assess insulin sensitivity in humans: the rapid insulin sensitivity test (RIST). Proc West Pharmacol Soc 2007; 50: 105-109.
34. Reid MA, Latour MG, Legare DJ, Rong N, Lautt WW. Comparison of the rapid insulin sensitivity test (RIST), the insulin tolerance test (ITT), and the hyperinsulinemic euglycemic clamp (HIEC) to measure insulin action in rats. Can J Physiol Pharmacol 2002; 80: 811-818.
35. Takayama S, Legare DJ, Lautt WW. Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc West Pharmacol Soc 2000; 43: 33-34.
36. Latour MG, Lautt WW. The hepatic vagus nerve in the control of insulin sensitivity in the rat. Auton Neurosci 2002; 95: 125-130.
37. Bates HE, Kiraly MA, Yue JT, Goche Montes D, Elliott ME, Riddell MC, Matthews SG, Vranic M. Recurrent intermittent restraint delays fed and fasting hyperglycemia and improves glucose return to baseline levels during glucose tolerance tests in the Zucker diabetic fatty rat - role of food intake and corticosterone. Metabolism 2007; 56: 1065-1075.
38. Pickavance L, Widdowson PS, King P, Ishii S, Tanaka H, Williams G. The development of overt diabetes in young Zucker diabetic fatty (ZDF) rats and the effects of chronic MCC-555 treatment. Br J Pharmacol 1998; 125: 767-770.
39. Corsetti JP, Sparks JD, Peterson RG, Smith RL, Sparks CE. Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats. Atherosclerosis 2000; 148: 231-241.
40. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007; 30: 263-269.
41. Kemmer FW, Berger M, Herberg L, Gries FA, Wirdeier A, Becker K. Glucose metabolism in perfused skeletal muscle. Demonstration of insulin resistance in the obese Zucker rat. Biochem J 1979; 178: 733-741.
42. Friedman JE, de Vente JE, Peterson RG, Dohm GL. Altered expression of muscle glucose transporter GLUT-4 in diabetic fatty Zucker rats (ZDF/Drt-fa). Am J Physiol 1991; 1: E782-E788.
43. Tateishi N, Higashi T, Naruse A, Nakashima K, Shiozaki H, Sakamoto Y. Rat liver glutathione: possible role as a reservoir of cysteine. J Nutr 1977; 107: 51-60.
44. Chander PN, Gealekman O, Brodsky SV, Elitok S, Tojo A, Crabtree M, Gross SS, Goligorsky MS. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004; 15: 2391-2403.
45. Toblli JE, Cao G, Rivas C, Munoz M, Giani J, Dominici F, Angerosa M. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens 2010; 28: 1007-1019.
46. Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P, Correia da Silva G, Teixeira N, Silva AS, Carvalho L, Teixeira F, Das UN. Exercise training decreases proinflammatory profile in Zucker diabetic (type 2) fatty rats. Nutrition 2009; 25: 330-339.
47. Song D, Kuo K-H, Yao R, Hutchings SR, Pang CCY. Inducible nitric oxide synthase depresses cardiac contractile function in Zucker diabetic fatty rats. Eur J Pharmacol 2008; 3: 253-259.
48. Khamaisi M, Kavel O, Rosenstock M, Porat M, Yuli M, Kaiser N, Rudich A. Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoximine. Biochem J 2000; 349: 579-586.
49. Li X, Wu X, Camacho R, Schwartz GJ, LeRoith D. Intracerebroventricular leptin infusion improves glucose homeostasis in lean type 2 diabetic MKR mice via hepatic vagal and non-vagal mechanisms. PLoS One 2011; 6: e17058.
50. Scherrer U, Sartori C. Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol 2000; 142: 315-323.
51. Deng G, Long Y, Yu Y-R, Li M-R. Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK-eNOS pathway. Int J Obes 2009; 34: 165-171.
52. Kawaguchi M, Koshimura K, Sohmiya M, Murakami Y, Gonda T, Kato Y. Effect of insulin on nitric oxide synthase-like immunostaining of arteries in various organs in Zucker diabetic fatty rats. Eur J Endocrinol 2001; 145: 343-349.
53. Gealekman O, Brodsky SV, Zhang F, Chander PN, Friedli C, Nasjletti A, Goligorsky MS. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: Amelioration with Ebselen. Kidney Int 2004; 66: 2337-2347.
54. Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD, Yorek MA. Progression of vascular and neural dysfunction in sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J Physiol Endocrinol Metab 2005; 289: E113-E122.
55. Lesniewski LA, Donato AJ, Behnke BJ, Woodman CR, Laughlin MH, Ray CA, Delp MD. Decreased NO signaling leads to enhanced vasoconstrictor responsiveness in skeletal muscle arterioles of the ZDF rat prior to overt diabetes and hypertension. Am J Physiol Heart Circ Physiol 2008; 294: H1840-H1850.